Codelivery of BCL2 and MCL1 Inhibitors Enabled by Phenylboronic Acid‐Functionalized Polypeptide Nanovehicles for Synergetic and Potent Therapy of Acute Myeloid Leukemia

Abstract Acute myeloid leukemia (AML) is the most refractory hematologic malignancy characterized by acute onset, rapid progression, and high recurrence rate. Here, codelivery of BCL2 (ABT199) and MCL1 (TW37) inhibitors using phenylboronic acid‐functionalized polypeptide nanovehicles to achieve syne...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Jiguo Xie, Xiaofei Zhao, Peng Zhang, Yueyue Zhang, Ru Cheng, Zhiyuan Zhong, Chao Deng
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2023-03-01
Reeks:	Advanced Science
Onderwerpen:	acute myeloid leukemia BCL2 inhibitor BN coordination boronic ester bond MCL1 inhibitor synergetic therapy
Online toegang:	https://doi.org/10.1002/advs.202204866
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!